Kymera Therapeutics, Inc. (KYMR)
NASDAQ·Healthcare·Biotechnology
$104.28
+3.97%
Mkt Cap $9.05B
Analyst Ratings
Buy
12
Hold
0
Sell
0
Price Target (61 analysts)
$125.29
Range $97.00 – $155.00
Implied Upside
+20.1%
Consensus $125.29 vs current $104.28
NASDAQ·Healthcare·Biotechnology
$104.28
+3.97%
Mkt Cap $9.05B
Buy
12
Hold
0
Sell
0
Price Target (61 analysts)
$125.29
Range $97.00 – $155.00
+20.1%
Consensus $125.29 vs current $104.28